Smith & Nephew PLC (SNN)
24.94
+0.19
(+0.77%)
USD |
NYSE |
May 07, 16:00
24.94
0.00 (0.00%)
After-Hours: 16:57
Smith & Nephew Total Return Level: 44.16 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 44.16 |
May 03, 2024 | 44.21 |
May 02, 2024 | 43.61 |
May 01, 2024 | 43.07 |
April 30, 2024 | 43.05 |
April 29, 2024 | 43.91 |
April 26, 2024 | 43.63 |
April 25, 2024 | 42.61 |
April 24, 2024 | 43.84 |
April 23, 2024 | 44.25 |
April 22, 2024 | 43.47 |
April 19, 2024 | 42.54 |
April 18, 2024 | 42.84 |
April 17, 2024 | 42.68 |
April 16, 2024 | 42.47 |
April 15, 2024 | 42.47 |
April 12, 2024 | 42.41 |
April 11, 2024 | 43.75 |
April 10, 2024 | 43.45 |
April 09, 2024 | 44.00 |
April 08, 2024 | 43.45 |
April 05, 2024 | 43.66 |
April 04, 2024 | 43.43 |
April 03, 2024 | 43.91 |
April 02, 2024 | 43.30 |
Date | Value |
---|---|
April 01, 2024 | 43.79 |
March 28, 2024 | 44.41 |
March 27, 2024 | 46.13 |
March 26, 2024 | 45.67 |
March 25, 2024 | 45.25 |
March 22, 2024 | 45.88 |
March 21, 2024 | 45.67 |
March 20, 2024 | 46.27 |
March 19, 2024 | 47.16 |
March 18, 2024 | 46.71 |
March 15, 2024 | 47.30 |
March 14, 2024 | 48.13 |
March 13, 2024 | 48.72 |
March 12, 2024 | 49.04 |
March 11, 2024 | 48.93 |
March 08, 2024 | 48.42 |
March 07, 2024 | 48.23 |
March 06, 2024 | 48.04 |
March 05, 2024 | 46.62 |
March 04, 2024 | 46.41 |
March 01, 2024 | 46.27 |
February 29, 2024 | 46.43 |
February 28, 2024 | 46.29 |
February 27, 2024 | 48.97 |
February 26, 2024 | 49.96 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
36.88
Minimum
Sep 27 2022
82.08
Maximum
Feb 20 2020
57.96
Average
57.54
Median
Oct 18 2021
Total Return Level Benchmarks
AstraZeneca PLC | 216.99 |
Adaptimmune Therapeutics PLC | 1.13 |
Biodexa Pharmaceuticals Plc | 1.11 |
Verona Pharma PLC | 14.95 |
NuCana PLC | 3.88 |